Enzymatic digestion of proteins before mass spectrometry analysis is a key process in metaproteomic 11 workflows. Canonical metaproteomic data processing pipelines typically involve matching spectra pro-12 duced by the mass spectrometer to a theoretical spectra database, followed by matching the identified 13 peptides back to parent proteins. However, the nature of enzymatic digestion produces peptides that 14 can be found in multiple proteins due to conservation or chance, presenting difficulties with protein and 15 functional assignment. To combat this challenge, we developed a peptide-centric metaproteomic work-16 flow focused on the analysis of human gut microbiome samples. Our workflow includes a curated peptide 17 database annotated with KEGG terms and a pathway enrichment analysis adapted for peptide level 18 data. Analysis using our peptide-centric workflow is fast and identifies more enriched KEGG pathways 19 than protein-centric analysis. Our workflow is open source and available as a web application or source 20 code to be run locally.
Introduction
Metaproteomics, the study of proteins from an environmental sample, is used to examine the dynamics and 23 composition of microbial communities in complex environments including human and animal microbiomes 24 (Moon et al., 2018; Cheng et al., 2018) , soil (Starke et al., 2019) and water samples (Mikan et al., 2019) . Figure 1 : We first used diamond blastp to align IGC proteins to the UniRef90 gene cluster database for annotation of IGC proteins with KEGG terms. In parallel, we completed an in silico trypsin digestion of IGC proteins into tryptic peptides that then inherited KEGG annotations from their parent proteins. Notably, redundant peptides inherited all possible KEGG annotations. In this example, the redundant peptide (grey) can be found in three proteins. Thus, its intensity is weighted by our confidence in the peptide's KEGG annotation. The redundant peptide is part of two proteins annotated with KO1 and one protein annotated with KO2, therefore we weight the peptide's intensity for KO1 and KO2 by 0.66 (2/3) and 0.33 (1/3) respectively. The weighted intensities are then be used in our modified GSVA pipeline where the weighted intensities are associated to the appropriate peptide gene set. 4 then divided by their corresponding sample-specific size factor. We removed peptides with intensities missing teomeXchange Consortium via the PRIDE (Perez-Riverol et al., 2019) intensities were used for the analyses for the three technical replicates (MTFM_3). Of the total detected peptides, 84.4% were found in our core peptide database and 62.4% had at least one associated KEGG term ( Figure S1b ).
Results
and peptide-levels distinguish treatment groups. To do so, we applied both protein and peptide-centric 179 metaproteomic workflows to two fecal microbiome datasets: Dataset 1, a fecal microbiome treated with two 180 concentrations of SAHA and Dataset 2, a fecal microbiome treated with metformin. PCA using both peptide 181 and protein group intensities is able to separate the high concentration of SAHA from the control DMSO 182 treatment of Dataset 1 (Figures 2a, 2b ). Clustering of treatments is similar using peptide and protein level 183 data analyses. In Dataset 2, PCA can also very clearly distinguish between a DMSO treated microbiome 184 from one treated with metformin using both peptide and protein group intensities (Figures 2c, 2d ). The 185 control DMSO treatment samples, however, cluster more tightly when using peptide intensities.
186
KEGG functional enrichment of metaproteomic data 187 We compared protein-and peptide-centric workflows for KEGG pathway enrichment using a GSVA frame- for all proteins in each protein group were considered for functional enrichment.
192
We computed GSVA scores for all samples in each dataset. To test if GSVA scores followed the same 193 trend in both workflows, we completed a correlation analysis of the median GSVA scores of pathways found 194 to be significantly enriched at either a peptide or protein level analysis. We found linear agreement of GSVA 195 scores between using protein and peptide level data sources with Pearson's correlation coefficients of 0.76 196 and 0.85 for Datasets 1 and 2 respectively ( Figure 3 ).
197
Using Dataset 1, we were able to complete GSVA on 70 and 87 protein and peptide gene sets respectively.
198
After protein and peptide gene set GSVA score ranking, a linear model in combination with an Empirical 199 Bayes approach, was used to identify differentially enriched KEGG pathways in each of the treatment con- while nine other KEGG pathways such as glycerolipid metabolism and selenocompound metabolism were 209 significantly altered after treatment with high levels of SAHA. Five of the same pathways were identified 210 as significant by both peptide-and protein-centric approaches, however, the peptide-centric approach was 211 able to identify more significantly enriched KEGG pathways than the protein-centric method ( Figure S2 ). Notably, significantly enriched KEGG pathways identified by the peptide-centric workflow were enriched in 213 the same direction in the protein-centric workflow in both datasets (Figure 4) .
214
There was adequate detection of protein-groups for GSVA analysis on 67 KEGG pathway gene sets when 215 considering the protein-centric analysis of Dataset 2. We identified 30 significant differentially enriched 216 KEGG pathways in fecal microbiomes cultured with meformin. Conversely, we were able to complete GSVA 217 on 94 gene sets using the peptide-centric approach, of which 47 were significantly enriched. Of the significantly 218 enriched KEGG pathways, 24 were identified by both peptide-and protein-centric approaches ( Figure S2c ). 220 We created a web-based peptide-centric workflow made available as a companion tool to MetaLab (Cheng Figure 4 : Heatmap visualizing GSVA scores of Dataset 1. Peptide centric workflow is presented on the left, and protein-centric on the right. A high score is visualized in coral and a low score in blue. A pathway is coloured in gray if the pathway is enriched in one condition, but not the other (BH adjusted p > 0.05). If the pathway is enriched in the peptide level analysis but not the protein level analysis, or vice versa, the pathway is not coloured in and is represented completely in white.
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of enzymatic digestion as seen in metaproteomics, fragmentation of cDNA for metatranscriptomic sample 236 preparation can be performed by physical methods, such as sonication (Marine et al., 2011) . The randomness 237 of sonication typically leads to cDNA reads that map to unique locations in reference genomes, increasing 238 the confidence of functional assignment.
239
In metaproteomics, the Protein Inference Problem, describing the challenges of peptide-to-protein assign-240 ment, can be even more difficult when considering the complexity of the microbiome. Because metaproteomic 241 analyses can identify more proteins that share the same peptide sequences through the inclusion of multi-242 ple microbial strains and species, protein group level analyses have been used to analyze proteins clustered 243 into groups by sequence similarity. However, assigning peptides to protein-groups leads to data loss where 244 researchers can lose statistical power and potentially important functional information of their microbial 245 community samples (e.g. Figures 4,5) . To combat the issues that can arise from protein group pipelines we 246 have created a peptide-centric workflow. By analysing metaproteomic data at the peptide level, we are able 247 to identify similar enriched KEGG pathways as analysis at the protein group level. Furthermore, we can 248 identify more enriched KEGG pathways at the peptide level compared to the protein level because we retain 249 more information (e.g. 12 vs 6 in Dataset 1 and 47 vs 31 in Dataset 2; Figures 4, 5, S2 ). Our peptide-centric 250 workflow is unique as it uses a weighted intensity for functional assignment that is proportional to our con-251 fidence in annotated KEGG terms. In addition, our database is small and reduces computational resources 252 required for a full database search.
253
To confirm the appropriateness of our approach, we looked at the biological relevance of the enriched 254 KEGG pathways in our peptide-centric results. For Dataset 1, a microbiome treated with SAHA, an HDAC Figure 5 : Heatmap visualizing GSVA scores of Dataset 2. Peptide centric workflow is presented on the left, and protein-centric on the right. A high score is visualized in coral and a low score in blue. If the pathway is enriched in the peptide level analysis but not the protein level analysis, or vice versa, the pathway is not coloured in and is represented completely in white.
inhibitor, we looked at the cited functional roles of acetylation in bacteria. Acetylation is a reversible Figure S2 : Venn diagrams depicting the overlap in enriched KEGG pathways identified using a GSVA framework and peptide vs protein level data.
